These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 24461312)

  • 1. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
    Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
    Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
    Pawlowski JW; Martin BR; McCabe GP; McCabe L; Jackson GS; Peacock M; Barnes S; Weaver CM
    Am J Clin Nutr; 2015 Sep; 102(3):695-703. PubMed ID: 26245807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study.
    Tousen Y; Uehara M; Abe F; Kimira Y; Ishimi Y
    Nutr J; 2013 Sep; 12():127. PubMed ID: 24034304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-sectional study of equol producer status and self-reported vasomotor symptoms.
    Newton KM; Reed SD; Uchiyama S; Qu C; Ueno T; Iwashita S; Gunderson G; Fuller S; Lampe JW
    Menopause; 2015 May; 22(5):489-95. PubMed ID: 25380274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of soy isoflavones in normal human breast tissue.
    Bolca S; Urpi-Sarda M; Blondeel P; Roche N; Vanhaecke L; Possemiers S; Al-Maharik N; Botting N; De Keukeleire D; Bracke M; Heyerick A; Manach C; Depypere H
    Am J Clin Nutr; 2010 Apr; 91(4):976-84. PubMed ID: 20164315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of whole soy and purified daidzein on ambulatory blood pressure and endothelial function--a 6-month double-blind, randomized controlled trial among Chinese postmenopausal women with prehypertension.
    Liu ZM; Ho SC; Chen YM; Tomlinson B; Ho S; To K; Woo J
    Eur J Clin Nutr; 2015 Oct; 69(10):1161-8. PubMed ID: 25782428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equol-producing status, isoflavone intake, and breast density in a sample of U.S. Chinese women.
    Tseng M; Byrne C; Kurzer MS; Fang CY
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1975-83. PubMed ID: 24019393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor-mediated effects of isoflavone supplementation were not observed in whole-genome gene expression profiles of peripheral blood mononuclear cells in postmenopausal, equol-producing women.
    van der Velpen V; Geelen A; Schouten EG; Hollman PC; Afman LA; van 't Veer P
    J Nutr; 2013 Jun; 143(6):774-80. PubMed ID: 23616509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production.
    Hall WL; Vafeiadou K; Hallund J; Bügel S; Koebnick C; Reimann M; Ferrari M; Branca F; Talbot D; Dadd T; Nilsson M; Dahlman-Wright K; Gustafsson JA; Minihane AM; Williams CM
    Am J Clin Nutr; 2005 Dec; 82(6):1260-8; quiz 1365-6. PubMed ID: 16332659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women.
    Liu ZM; Ho SC; Woo J; Chen YM; Wong C
    Menopause; 2014 Jun; 21(6):653-60. PubMed ID: 24149925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Legume, soy, tofu, and isoflavone intake and endometrial cancer risk in postmenopausal women in the multiethnic cohort study.
    Ollberding NJ; Lim U; Wilkens LR; Setiawan VW; Shvetsov YB; Henderson BE; Kolonel LN; Goodman MT
    J Natl Cancer Inst; 2012 Jan; 104(1):67-76. PubMed ID: 22158125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production.
    Hall WL; Vafeiadou K; Hallund J; Bugel S; Reimann M; Koebnick C; Zunft HJ; Ferrari M; Branca F; Dadd T; Talbot D; Powell J; Minihane AM; Cassidy A; Nilsson M; Dahlman-Wright K; Gustafsson JA; Williams CM
    Am J Clin Nutr; 2006 Mar; 83(3):592-600. PubMed ID: 16522905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women.
    Fuhrman BJ; Teter BE; Barba M; Byrne C; Cavalleri A; Grant BJ; Horvath PJ; Morelli D; Venturelli E; Muti PC
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):33-42. PubMed ID: 18199709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women.
    Frankenfeld CL; McTiernan A; Aiello EJ; Thomas WK; LaCroix K; Schramm J; Schwartz SM; Holt VL; Lampe JW
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1156-62. PubMed ID: 15247126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dairy consumption is a significant correlate of urinary equol concentration in a representative sample of US adults.
    Frankenfeld CL
    Am J Clin Nutr; 2011 May; 93(5):1109-16. PubMed ID: 21389178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal cut-off value for equol-producing status in women: The Japan Nurses' Health Study urinary isoflavone concentration survey.
    Ideno Y; Hayashi K; Nakajima-Shimada J; Onizuka Y; Kishi M; Ueno T; Uchiyama S
    PLoS One; 2018; 13(7):e0201318. PubMed ID: 30048499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
    North American Menopause Society
    Menopause; 2011 Jul; 18(7):732-53. PubMed ID: 21685820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large inter-individual variation in isoflavone plasma concentration limits use of isoflavone intake data for risk assessment.
    van der Velpen V; Hollman PC; van Nielen M; Schouten EG; Mensink M; Van't Veer P; Geelen A
    Eur J Clin Nutr; 2014 Oct; 68(10):1141-7. PubMed ID: 24939433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.
    Frankenfeld CL; Atkinson C; Wähälä K; Lampe JW
    Eur J Clin Nutr; 2014 Apr; 68(4):526-30. PubMed ID: 24569543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women.
    Liu ZM; Ho SC; Chen YM; Ho S; To K; Tomlinson B; Woo J
    Mol Nutr Food Res; 2014 Apr; 58(4):709-17. PubMed ID: 24273218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.